[1]
Samuel Rigilin, K. K. Kunjal, A. R. Thayyil, and R. Shabaraya, “FDA Regulatory Implications for Co-crystals and recent Co-crystal Patents”, Int J Drug Reg Affairs, vol. 10, no. 3, pp. 10-18, Sep. 2022.